Mustang Bio Inc (MBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,984 | 12,657 | 14,231 | 6,839 | 3,525 |
| Receivables | 217 | 217 | 467 | 402 | 237 |
| Other current assets | 0 | 0 | 0 | 1,165 | 2,209 |
| TOTAL | $19,361 | $13,046 | $14,909 | $8,606 | $6,055 |
| Non-Current Assets | |||||
| PPE Net | 0 | 0 | 0 | 371 | 421 |
| Other Non-Current Assets | 0 | 0 | 0 | 331 | 717 |
| TOTAL | $N/A | $N/A | $N/A | $702 | $1,138 |
| Total Assets | $19,361 | $13,046 | $14,909 | $9,308 | $7,193 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,911 | 7,500 | 8,337 | 9,486 | 12,061 |
| Accrued Expenses | 2,529 | 2,504 | 2,813 | 2,667 | 2,535 |
| TOTAL | $9,440 | $10,004 | $11,150 | $12,609 | $15,038 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 422 | 541 |
| TOTAL | $150 | $150 | $150 | $572 | $811 |
| Total Liabilities | $9,590 | $10,154 | $11,300 | $13,181 | $15,849 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,299 | 7,240 | 4,378 | 3,306 | 956 |
| Common Shares | 1 | N/A | 0 | 616 | 3 |
| Retained earnings | -398,106 | -397,638 | -396,876 | -396,723 | -395,771 |
| TOTAL | $9,771 | $2,892 | $3,609 | $-3,873 | $-8,656 |
| Total Liabilities And Equity | $19,361 | $13,046 | $14,909 | $9,308 | $7,193 |